TRYP.CN
Price:
$0.06
Market Cap:
$5.79M
Tryp Therapeutics Inc., a pharmaceutical company, focuses on identifying and developing compounds for diseases with high unmet medical needs. The company's lead development program is (PFN), which is designed to treat neuropsychiatric disorders through the dosing of formulations of synthetic psilocybin. Its PFN program candidates include TRP-8802 and TRP-8803 for fibromyalgia, phantom limb pain, binge eating disorder, complex regional pain syndrome, and hypothalamic obesity. The company has an agreement with the Calvert Labs to design and execute exploratory studies related to psilocybin-for-neuropsychiatric disorders program; and a service agreement with Fluence to provide design and traini...[Read more]
Industry
Biotechnology
IPO Date
2020-12-18
Stock Exchange
CNQ
Ticker
TRYP.CN
According to Tryp Therapeutics Inc.’s latest financial reports and current stock price. The company's current ROE is 131.45%. This represents a change of 344.93% compared to the average of 29.54% of the last 4 quarters.
The mean historical ROE of Tryp Therapeutics Inc. over the last ten years is -196.17%. The current 131.45% ROE has changed -167.01% with respect to the historical average. Over the past ten years (40 quarters), TRYP.CN's ROE was at its highest in in the November 2022 quarter at 540.98%. The ROE was at its lowest in in the August 2022 quarter at -195.45%.
Average
-196.17%
Median
-129.00%
Minimum
-666.73%
Maximum
140.07%
Discovering the peaks and valleys of Tryp Therapeutics Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 924.75%
Maximum Annual ROE = 140.07%
Minimum Annual Increase = -121.01%
Minimum Annual ROE = -666.73%
Year | ROE | Change |
---|---|---|
2023 | 140.07% | -121.01% |
2022 | -666.73% | 183.63% |
2021 | -235.07% | 924.75% |
The current ROE of Tryp Therapeutics Inc. (TRYP.CN) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-253.91%
5-year avg
-196.17%
10-year avg
-196.17%
Tryp Therapeutics Inc.’s ROE is greater than HAVN Life Sciences Inc. (-302.07%), greater than Cybin Inc. (-40.40%), greater than Entheon Biomedical Corp. (-114.00%), greater than Psyched Wellness Ltd. (-62.59%), greater than Revive Therapeutics Ltd. (-61.00%),
Company | ROE | Market cap |
---|---|---|
-302.07% | $442.16K | |
-40.40% | $298.28M | |
-114.00% | $1.20M | |
-62.59% | $7.20M | |
-61.00% | $2.09M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Tryp Therapeutics Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Tryp Therapeutics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Tryp Therapeutics Inc.'s ROE?
How is the ROE calculated for Tryp Therapeutics Inc. (TRYP.CN)?
What is the highest ROE for Tryp Therapeutics Inc. (TRYP.CN)?
What is the 3-year average ROE for Tryp Therapeutics Inc. (TRYP.CN)?
What is the 5-year average ROE for Tryp Therapeutics Inc. (TRYP.CN)?
How does the current ROE for Tryp Therapeutics Inc. (TRYP.CN) compare to its historical average?